AMERICAN EXPRESS CO (AXP): what the price requires
The current priced-in claim for AMERICAN EXPRESS CO (AXP) is temporarily suppressed because the live engine record is unavailable. The dated report remains a snapshot, not a current market read.
Generated: 2026-07-13 · Source: https://boothcheck.com/report/AXP
Headline
| Field | Value |
|---|---|
| Ticker | AXP |
| Company | AMERICAN EXPRESS CO |
| Current price | $353.51/sh |
| Composition | U.S. Consumer Services (USCS) 59% / Commercial Services (CS) 28% / Global Merchant and Network Services (GMNS) 13% |
What The Price Requires (Inversion)
The assumption today's price embeds, recovered by inverting the valuation.
| Field | Value |
|---|---|
| Inversion basis | financials |
| Price-to-book | 7.10x |
The implied return on book is non-physical at this price-to-book and is suppressed as misleading. The rarity read below is the honest signal.
How unusual the bet is: extreme
| Reference | Value |
|---|---|
| vs own history | +5.00σ |
| cohort percentile (of 72 peers) | 81 |
| sustained it ~10 years at this level | 24% |
| implied end-window share | 0% |
Valuation X-Ray
The price is justified by relative-multiple and growth-DCF; asset-based/earnings-power land below the price.
How the valuation models price the stock relative to the market price. Price/FV above 1.0 means the market pays more than that lens defends (expensive); at or below 1.0 the lens can defend the price.
| Family | Median price/FV | Models | Reads |
|---|---|---|---|
| Asset | 1.65x | 4 | expensive |
| Earnings | 2.30x | 4 | expensive |
| Relative | 1.24x | 4 | expensive |
| Growth | 0.73x | 2 | justifies |
Families that justify the price: Relative, Growth Families that call it expensive: Asset, Earnings
The models below discount at their own flat-beta convention rates (cost of equity 9.3%, WACC 8.2%); the inversion above states its own rate.
Per-Model Detail (n=14)
| Model | Family | FV | Price/FV | Applicable | Methodology |
|---|---|---|---|---|---|
| DCF Perpetual Growth | Growth | $658.99 | 0.54x | yes | FCF base $15.1B, growth 11% (input: historical growth), terminal g 4.0%, WACC 8.2%, 6yr projection |
| DCF Exit Multiple | Growth | $0.00 | — | no | Negative/zero FCF or EBITDA — equity value floored at $0 |
| Relative Valuation | Relative | $325.26 | 1.09x | yes | P/E 18x (sector median), scenarios: 14.9x / 18.0x / 21.1x (bear / base = sector held flat / bull), EV/EBITDA 12x |
| Simple DDM | Growth | — | — | no | — |
| Two-Stage DDM | Growth | — | — | no | — |
| Simple Excess Return | Asset | $176.82 | 2.00x | yes | BV/sh $49.56, ROE (TTM) 33.0%, ke 9.3% |
| Two-Stage Excess Return | Asset | $351.57 | 1.01x | yes | 5yr excess ROE then converge to ke=9.3% |
| Discounted Future Market Cap | Growth | $379.65 | 0.93x | yes | Rev $74.2B, growth 11% (input: historical growth; tapered), Terminal P/S: 2.7x / 3.3x / 3.8x (bear / base = today's held flat / bull, cap 8x) |
| Peter Lynch Fair Value | Relative | $201.49 | 1.75x | yes | EPS $16.02, growth 13% (input: historical EPS growth), PEG=1.72 (Overvalued) |
| Margin Trajectory | Growth | — | — | no | — |
| Earnings Power Value | Earnings | — | — | no | — |
| Residual Income | Asset | $273.38 | 1.29x | yes | BV $49.56 + 5yr PV of (ROE (TTM) 33.0% − Kₑ 9.3%) × BV; BV grows 8.8%/yr |
| Graham Number | Asset | $133.65 | 2.65x | yes | √(22.5 × EPS $16.02 × BVPS $49.56) — Graham's conservative floor |
| EV/EBITDA Relative | Relative | — | — | no | — |
| FCF Yield | Earnings | $137.63 | 2.57x | yes | FCF $14324.0M / Kₑ 9.3% — zero-growth perpetuity |
| SBC-Adj FCF Yield | Earnings | $128.23 | 2.76x | yes | SBC-adj FCF $13.73B (FCF $14.32B − SBC $0.60B) capitalized at Kₑ |
| Ben Graham Formula | Earnings | $451.86 | 0.78x | yes | EPS $16.02 × (8.5 + 2×12.6%) × (4.4 / 5.3%) |
| ROIC-Justified P/B | Asset | — | — | no | — |
| P/Sales Sector | Relative | $270.30 | 1.31x | yes | Revenue $74.17B × sector P/S 2.5x |
| PEG Fair Value | Relative | $302.24 | 1.17x | yes | EPS $16.02 × (PEG 1.5 × growth 12.6% (input: historical EPS growth)) → PE 18.9x |
| Earnings Yield | Earnings | $173.19 | 2.04x | yes | EPS $16.02 / required return 9.3% (Rf 4.3% + ERP 5.0%) |
| Funds From Operations Multiple | Relative | — | — | no | — |
| Clinical Phase NPV | Growth | — | — | no | — |
| Merton | Asset | — | — | no | — |
| V5 Mechanical | — | — | — | no | — |
Solvency
| Field | Value |
|---|---|
| Share count CAGR (buyback) | -2.5% |
Deposit/float-funded balance sheet: debt is funding, not corporate leverage, and GAAP operating cash flow follows loan flows. Net-debt, interest-coverage, and cash-burn lenses do not apply. The solvency frame for a financial is regulatory capital and payout capacity (CET1, stress buffer, dividends plus buybacks against earnings).
Bullet Takeaways
At $338.16 (as of June 27, 2026) American Express trades near the middle of its valuation methods, with the relative-multiple and growth frames at or above the price and the asset and earnings-power frames below. The growth and relative-multiple lenses support the quote; the asset and earnings-power lenses do not.
The spread-business model is the engine: a trailing ROE near 33% on book of roughly $50 a share, which is among the highest in financials and is what justifies a premium to book. Q1 2026 EPS rose 18% to $4.28 on revenue up 11% to $18.9 billion.
The model reads the current return profile as extreme against history and cohort, so the price assumes Amex sustains that elite ROE. Billed business grew 10%, the strongest in three years, and management reaffirmed full-year EPS guidance of $17.30 to $17.90.
Bull Case
Start with where the price sits against the methods, because for Amex the spread is reassuring rather than alarming. At $338.16 the relative-multiple and growth frames reach or exceed the price: a perpetual-growth DCF near $666, a two-stage excess-return mark near $352, a discounted future market cap near $363, and a relative P/E mark near $325 on an 18x sector median. The growth lenses defend the price outright and the relative-multiple read sits close to it; the market is not paying much beyond what those frames support. This is not a stock priced beyond every frame; it is a premium financial trading roughly in line with what its growth and returns support.
The business model is why the returns are so high. American Express is a closed-loop spend-centric network that earns discount revenue on every transaction plus annual card fees, and it skews to affluent, high-spending cardmembers who default less and spend more. Trailing ROE near 33% on book value of about $50 a share is among the best in financials, and the FY2025 10-K describes how management evaluates its reportable segments through the lens of the chief operating decision maker across U.S. Consumer Services, Commercial Services, and Global Merchant and Network Services. That premium, fee-driven model is structurally more resilient than a pure lender.
The Q1 2026 print shows the model accelerating. EPS rose 18% to $4.28, revenue grew 11% to $18.9 billion, and net income was $3.0 billion. Billed business reached $428 billion, up 10% and the strongest quarterly growth in three years, with spending momentum driven increasingly by Millennial and Gen Z cardmembers adopting the premium products. Management reaffirmed full-year guidance of 9% to 10% revenue growth and EPS of $17.30 to $17.90 while choosing to reinvest in marketing and technology. A network compounding spend at double digits with a young, growing premium base and a sector-leading ROE is the kind of franchise where a price the growth and relative frames both support is a reasonable entry, not a stretch.
Bear Case
The qualitative reality first: American Express is a consumer-credit and discretionary-spending business dressed as a premium network, and both halves of that are cyclical. Cardmember spending and the discount revenue it generates rise with consumer confidence and fall when households retrench, and the lending book carries credit risk that normalizes upward when the economy slows. The price assumes the current double-digit billed-business growth and elite returns continue, but those are peak-cycle conditions, and a premium consumer is still a consumer who pulls back in a downturn.
The numbers confirm how much of the price leans on continuation. The model flags Amex's return profile as extreme, an ownZ of 4.66 that is beyond both its own historical panel and its peer cohort, meaning the trailing ROE near 33% sits at the very top of what the company has ever earned. Premium-to-book valuations on financials depend on that ROE-minus-cost-of-equity spread holding. When the conservative frames cluster between $134 and $200, the gap to the price is the premium being paid for the elite return continuing indefinitely.
The specific dependencies are credit and reinvestment. Management is increasing marketing and technology spend, which supports growth but pressures near-term margins, and the heavy investment in cardmember rewards is what retains the affluent base. If credit losses normalize from today's benign levels, if affluent spending slows, or if competition in premium cards forces richer rewards that compress the net spread, the ROE reverts toward the cohort and the premium to book compresses. The price-to-fundamentals disconnect is not that Amex is a weak business, it is excellent, but that the price capitalizes a top-of-history return profile as if it were the new baseline. The conservative frames, sitting far below the quote, are the reminder of where the stock would settle if the cycle turns.
Valuation
American Express is a financial, so the valuation runs on return on equity against book value rather than a clean cash-flow lever. The relative-multiple and growth frames justify the price while the asset and earnings-power frames say expensive. The model characterizes the priced-in return profile as extreme, the highest reading in this batch.
The model X-ray shows the split. The growth and relative frames support the price: a perpetual-growth DCF near $666 on 11% FCF growth, a two-stage excess-return mark near $352, a discounted future market cap near $363, and a relative P/E mark near $325 that sits right at the quote. The conservative frames sit below: the simple excess-return mark near $177, residual income near $273, the Graham number near $134, and the FCF-yield mark near $138.
The spread is the information. The growth lenses defend the $338 price outright and the relative-multiple read sits within about a fifth of it, which is why the read is justified-by-growth rather than beyond-all-frames. The price is not a verdict on whether American Express is a good business, its returns and network are elite. It is a measure of how much continued top-of-history profitability the market has booked: a sustained ROE near the best Amex has ever earned, with double-digit billed-business growth carrying the premium to book.
Catalysts
The near-term driver is billed-business momentum and the credit backdrop. Q1 2026 billed business reached $428 billion, up 10% and the strongest quarterly growth in three years, with EPS up 18% to $4.28 on revenue of $18.9 billion. Whether spending growth holds, particularly among the Millennial and Gen Z cardmembers management highlighted as the fastest-growing cohort, is the swing factor for the year.
Guidance and reinvestment are the structural catalysts. Management reaffirmed full-year 2026 guidance of 9% to 10% revenue growth and EPS of $17.30 to $17.90, while choosing to increase marketing and technology investment to capture long-term growth. The watch item is whether that reinvestment sustains the spend and retention flywheel without eroding margins.
Credit normalization is the key risk to monitor. Watch billed-business growth, net card-fee growth, credit-loss provisions and delinquency trends as they move off benign levels, the pace of marketing and rewards spend, and competitive dynamics in premium cards that could pressure the net spread.
Sources: American Express Q1 2026 earnings release and Grafa (Q1 2026 results, EPS $4.28 up 18%, revenue $18.9B up 11%, billed business $428B up 10%), Investing.com and The Globe and Mail (reaffirmed full-year guidance of 9 to 10% revenue growth and $17.30 to $17.90 EPS, increased marketing and technology investment, Millennial and Gen Z spending momentum).
Peer Cohorts (Per Segment, With Filing Citations)
U.S. Consumer Services (USCS) (reported)
- COF (CAPITAL ONE FINANCIAL CORP)
- (no filing in the citation store)
- SYF (Synchrony Financial)
- (no filing in the citation store)
- BFH (Bread Financial Holdings, Inc.)
- (no filing in the citation store)
- SLM (SLM Corp)
- (no filing in the citation store)
- SOFI (SoFi Technologies, Inc.)
- (no filing in the citation store)
Commercial Services (CS) (reported)
- COF (CAPITAL ONE FINANCIAL CORP)
- (no filing in the citation store)
- CPAY (Corpay, Inc)
- (no filing in the citation store)
- WEX (WEX Inc.)
- (no filing in the citation store)
- PYPL (PayPal Holdings, Inc.)
- (no filing in the citation store)
- BFH (Bread Financial Holdings, Inc.)
- (no filing in the citation store)
- SYF (Synchrony Financial)
- (no filing in the citation store)
International Card Services (ICS) (reported)
- COF (CAPITAL ONE FINANCIAL CORP)
- (no filing in the citation store)
- SYF (Synchrony Financial)
- (no filing in the citation store)
- BFH (Bread Financial Holdings, Inc.)
- (no filing in the citation store)
Global Merchant and Network Services (GMNS) (reported)
- V (VISA INC.)
- (no filing in the citation store)
- MA (Mastercard Inc)
- (no filing in the citation store)
- PYPL (PayPal Holdings, Inc.)
- (no filing in the citation store)
- FIS (Fidelity National Information Services, Inc.)
- (no filing in the citation store)
- FISV (FISERV INC)
- (no filing in the citation store)
- GPN (GLOBAL PAYMENTS INC.)
- (no filing in the citation store)
Methodology Note
- Priced-in inversion: the valuation is inverted on the current price to recover the operating-income growth, duration, and steady-state margin the price embeds (ROE for financials, FFO growth for REITs).
- Valuation x-ray: the valuation models, grouped into four families (asset, earnings, relative, growth). Each model is expressed as a price/FV ratio (distance from price), not a point fair-value estimate. The spread across families is the disagreement.
- Solvency: net cash/debt, net-debt-to-NOPAT, interest coverage, and share-count CAGR from EDGAR financials (net debt / FFO and fixed-charge coverage for REITs; regulatory-capital framing for financials).
- Peer cohorts: per-segment comparables with deep-linkable SEC filing citations.
Fundamentals sourced from SEC EDGAR filings. Current price from Databento. The priced-in inversion and valuation x-ray are computed by the boothcheck engine; narrative composed by AI from the structured data.